was read the article
array:23 [ "pii" => "S0365059624000588" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.11.004" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "929" "copyright" => "Sociedade Brasileira de Dermatologia" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "pt" => array:18 [ "pii" => "S2666275224000614" "issn" => "26662752" "doi" => "10.1016/j.abdp.2024.03.016" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "929" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "pt" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo original</span>" "titulo" => "Avaliação dermatológica de pacientes pediátricos no complexo da esclerose tuberosa (CET)" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => "pt" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "662" "paginaFinal" => "669" ] ] "contieneResumen" => array:1 [ "pt" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 978 "Ancho" => 1505 "Tamanyo" => 146336 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">(A‐B) Máculas hipomelanóticas no abdme (A) e placa de Shagreen no dorso de paciente adolescente (B).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Beatriz Azevedo Nunes, Ana Karolina Ferreira Gonçalves Romano, Mariana Aparecida Pasa Morgan, Alice Andrade Gonçalves, Laís Faria Masulk Cardozo, Luiz Gustavo Dufner de Almeida, Luciana Amaral Haddad, Ana Chrystina de Souza Crippa, Sergio Antonio Antoniuk, Kerstin Taniguchi Abagge" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Beatriz Azevedo" "apellidos" => "Nunes" ] 1 => array:2 [ "nombre" => "Ana Karolina Ferreira Gonçalves" "apellidos" => "Romano" ] 2 => array:2 [ "nombre" => "Mariana Aparecida Pasa" "apellidos" => "Morgan" ] 3 => array:2 [ "nombre" => "Alice Andrade" "apellidos" => "Gonçalves" ] 4 => array:2 [ "nombre" => "Laís Faria Masulk" "apellidos" => "Cardozo" ] 5 => array:2 [ "nombre" => "Luiz Gustavo Dufner" "apellidos" => "de Almeida" ] 6 => array:2 [ "nombre" => "Luciana Amaral" "apellidos" => "Haddad" ] 7 => array:2 [ "nombre" => "Ana Chrystina de Souza" "apellidos" => "Crippa" ] 8 => array:2 [ "nombre" => "Sergio Antonio" "apellidos" => "Antoniuk" ] 9 => array:2 [ "nombre" => "Kerstin Taniguchi" "apellidos" => "Abagge" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0365059624000588" "doi" => "10.1016/j.abd.2023.11.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624000588?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275224000614?idApp=UINPBA00008Z" "url" => "/26662752/0000009900000005/v2_202409060549/S2666275224000614/v2_202409060549/pt/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S036505962400103X" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.10.003" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "962" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Doppler ultrasound protocol for patients with hidradenitis suppurativa" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "670" "paginaFinal" => "679" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1250 "Ancho" => 2083 "Tamanyo" => 257092 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Intermammary region.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ariany Tomaz de Aquino Saran Denofre, Carolina Meloni Stecca, Juliana Yumi Massuda Serrano, Thais Helena Buffo, Rachel Polo Dertkigil, Renata Ferreira Magalhães" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Ariany Tomaz de Aquino Saran" "apellidos" => "Denofre" ] 1 => array:2 [ "nombre" => "Carolina Meloni" "apellidos" => "Stecca" ] 2 => array:2 [ "nombre" => "Juliana Yumi Massuda" "apellidos" => "Serrano" ] 3 => array:2 [ "nombre" => "Thais Helena" "apellidos" => "Buffo" ] 4 => array:2 [ "nombre" => "Rachel Polo" "apellidos" => "Dertkigil" ] 5 => array:2 [ "nombre" => "Renata Ferreira" "apellidos" => "Magalhães" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S266627522400122X" "doi" => "10.1016/j.abdp.2024.05.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522400122X?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S036505962400103X?idApp=UINPBA00008Z" "url" => "/03650596/0000009900000005/v2_202409130645/S036505962400103X/v2_202409130645/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0365059624001065" "issn" => "03650596" "doi" => "10.1016/j.abd.2023.12.003" "estado" => "S300" "fechaPublicacion" => "2024-09-01" "aid" => "965" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Continuing Medical Education</span>" "titulo" => "Hailey-Hailey disease: clinical, diagnostic and therapeutic update" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "651" "paginaFinal" => "661" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0040" "etiqueta" => "Figure 8" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr8.jpeg" "Alto" => 1466 "Ancho" => 1675 "Tamanyo" => 380446 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0040" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Circinate erythematous plaques with peripheral vesicles, erosions and desquamation on the back and arms.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Adriana Maria Porro, Camila Arai Seque, Denise Miyamoto, Diego Vanderlei Medeiros da Nóbrega, Milvia Maria Simões e Silva Enokihara, Claudia Giuli Santi" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Adriana Maria" "apellidos" => "Porro" ] 1 => array:2 [ "nombre" => "Camila" "apellidos" => "Arai Seque" ] 2 => array:2 [ "nombre" => "Denise" "apellidos" => "Miyamoto" ] 3 => array:2 [ "nombre" => "Diego" "apellidos" => "Vanderlei Medeiros da Nóbrega" ] 4 => array:2 [ "nombre" => "Milvia Maria" "apellidos" => "Simões e Silva Enokihara" ] 5 => array:2 [ "nombre" => "Claudia" "apellidos" => "Giuli Santi" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2666275224001255" "doi" => "10.1016/j.abdp.2024.05.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275224001255?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059624001065?idApp=UINPBA00008Z" "url" => "/03650596/0000009900000005/v2_202409130645/S0365059624001065/v2_202409130645/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "A dermatological assessment of pediatric patients with tuberous sclerosis complex (TSC)" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "662" "paginaFinal" => "669" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Beatriz Azevedo Nunes, Ana Karolina Ferreira Gonçalves Romano, Mariana Aparecida Pasa Morgan, Alice Andrade Gonçalves, Laís Faria Masulk Cardozo, Luiz Gustavo Dufner de Almeida, Luciana Amaral Haddad, Ana Chrystina de Souza Crippa, Sergio Antonio Antoniuk, Kerstin Taniguchi Abagge" "autores" => array:10 [ 0 => array:3 [ "nombre" => "Beatriz Azevedo" "apellidos" => "Nunes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Ana Karolina Ferreira Gonçalves" "apellidos" => "Romano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Mariana Aparecida" "apellidos" => "Pasa Morgan" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Alice Andrade" "apellidos" => "Gonçalves" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Laís Faria Masulk" "apellidos" => "Cardozo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Luiz Gustavo Dufner" "apellidos" => "de Almeida" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 6 => array:3 [ "nombre" => "Luciana Amaral" "apellidos" => "Haddad" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 7 => array:3 [ "nombre" => "Ana Chrystina de Souza" "apellidos" => "Crippa" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 8 => array:3 [ "nombre" => "Sergio Antonio" "apellidos" => "Antoniuk" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 9 => array:4 [ "nombre" => "Kerstin Taniguchi" "apellidos" => "Abagge" "email" => array:1 [ 0 => "kerstinabagge@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Department of Pediatrics, Universidade Federal do Paraná, Curitiba, PR, Brazil" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Postgraduate Program in Child and Adolescent Health, Complexo Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Genetics and Evolutionary Biology, Centro de Pesquisa do Genoma Humano e Células-Tronco, Instituto de Biociências, Universidade de São Paulo, São Paulo, SP, Brazil" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1106 "Ancho" => 1505 "Tamanyo" => 141278 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">(A‒B) Confetti-like lesions (arrows) in the anterior tibial region (A) and ungual fibromas in 4<span class="elsevierStyleSup">th</span> and 5<span class="elsevierStyleSup">th</span> fingers of an adult patient (B).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Tuberous Sclerosis Complex (TSC) is a neurocutaneous syndrome with variable phenotypes and autosomal dominant inheritance. It is due to pathogenic DNA alterations in either <span class="elsevierStyleItalic">TSC1</span> (OMIM 605284) or <span class="elsevierStyleItalic">TSC2</span> (OMIM 191092) genes and is characterized by benign tumors (hamartomas) in distinct organs, mainly the brain, skin, heart, kidneys, and lungs.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> The <span class="elsevierStyleItalic">TSC1</span> gene (9q34) encodes hamartin, and <span class="elsevierStyleItalic">TSC2</span> (16p13.3) codes for tuberin. Under physiological conditions, hamartin, tuberin and TBC1D7 (OMIM 612655) proteins form a cytoplasmic complex that suppresses cell growth by inhibiting the mechanistic Target of Rapamycin (mTOR).<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,3,4</span></a><span class="elsevierStyleItalic">TSC1</span> or <span class="elsevierStyleItalic">TSC2</span> bi-allelic loss of function impairs the inhibitory effect on the mTOR pathway, causing abnormal cell differentiation and growth, resulting in hamartomatous lesions (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–5</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">Since 2012 the presence of a pathogenic alteration in <span class="elsevierStyleItalic">TSC1</span> or <span class="elsevierStyleItalic">TSC2</span> is a definite and sufficient criterion to diagnose TSC, regardless of the clinical findings.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> In 2021, the genetic diagnostic criterion was reaffirmed, and the combination of clinical criteria leading to definite or possible clinical diagnoses was maintained (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> There were however few changes in the clinical criteria. Multiple cortical tubers and/or radial migration lines have replaced the general term cortical dysplasia as a major criterion, and sclerotic bone lesions were reinstated as a minor criterion (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Patients with definite, possible, or suspected TSC diagnosis should be followed up by a multidisciplinary team for the early identification of signs and symptoms, clinical management, and therapeutic intervention, resulting in better clinical outcomes.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The association between TSC genotypes and phenotypes has been studied, highlighting <span class="elsevierStyleItalic">TSC2</span> alterations more frequently among patients with earlier presentations of seizures, the presence of West syndrome (epileptic/infantile spasms with onset in infancy or early childhood associated with hypsarrhythmia and developmental regression), and more severe cognitive deficit.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Although genotype-phenotype analyses mainly focus on neurological and renal signs, which are the major causes of morbidity and mortality,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> dermatological signs are one of the earliest clinical presentations, and their detection can lead to suspected TSC.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">TSC has been often underdiagnosed notably in developing countries.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> The early onset of some cutaneous signs is highly suggestive of TSC (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Given their importance to the diagnosis and treatment of this neurocutaneous genetic disorder, this study aimed at characterizing the skin lesions of 37 patients with definite clinical and genetic diagnoses of TSC. The authors additionally classified patients according to the gene involved and verified in each gene category the frequency of specific skin lesions. The authors describe in the TSC cohort a significant association between ungual fibromas and TSC2 alterations.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Subjects and methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">This observational, analytical and cross-sectional study was conducted at the Department of Pediatrics of the Clinics Hospital Complex of the Federal University of Paraná (CHC-UFPR), Curitiba, Brazil. The study protocol was approved by the CHC/UFPR Research (CAAE no. 67137317.5.0000.0096) and the University of São Paulo (CAAE no. 12572913.3.3002.5479 and 48259715.2.3003.5505) Ethics Committees.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Patients included in the study were clinically diagnosed with TSC according to Northrup et al. (2013)<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> and had a pathogenic DNA variant previously identified by Sanger, Multiplex Ligation-dependent Probe Amplification (MLPA) or Next-Generation Sequencing (NGS) in either <span class="elsevierStyleItalic">TSC1</span> (NM_000368.4) or <span class="elsevierStyleItalic">TSC2</span> (NM_000548.3) genes at the University of São Paulo, São Paulo, Brazil (data not shown). After the publication of the updated diagnostic criteria (Northrup et al., 2021),<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> data were reviewed accordingly and no alteration was made. In this ambispective study, once the family had provided written informed consent, the medical records were retrospectively reviewed. Then patients were prospectively seen by the Pediatric Dermatology team during a joint effort for the care of TSC patients in Oct/2021 and Oct/2022. Information (identification, age, dates, genetic study result, and description of the skin lesions) was registered and clinical lesions were photographed. Data were statistically analyzed in Excel®.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The sample was non-probabilistically and systematically selected by convenience, in order of appointment and admission to the study. Measures of central tendency and dispersion were expressed as mean ± standard deviation for continuous variables with symmetrical distribution and median (Interquartile Range [IQR]) for those with asymmetrical distribution. Categorical variables were expressed as absolute and relative frequencies. The Mann-Whitney non-parametric test was used to estimate the difference between continuous variables with asymmetric distribution and the Fisher’s exact and Pearson’s Chi-Square tests were used to estimate the difference between categorical variables. All tests considered a minimum significance level of 5%, 10% type II error, and magnitude of the effect of estimated difference between mutated genes four times.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Results</span><p id="par0040" class="elsevierStylePara elsevierViewall">The study sample comprised a total of 37 patients (36 unrelated patients), with definite clinical and genetic diagnoses of TSC, including 20 (54.1%) boys and 17 (45.9%) girls. All of them had at least one dermatological sign considered as a TSC diagnostic criterion (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). All patients had first skin lesion onset before 18 years of age. The median age at TSC diagnosis was 18 months (IQR: 8‒60), and the median age at dermatologic evaluation was 16 years (IIQ: 9‒24.5).</p><p id="par0045" class="elsevierStylePara elsevierViewall">Twenty-seven families could inform the first cutaneous sign identified in the patient. The patients’ median age at its onset was 3 months (IQR: 0‒19), and the most frequent skin lesion first identified was hypomelanotic leaf macula (25/27; p < 0.001). Considering patients according to sex, no difference was observed in first cutaneous signs, age at its onset, age at TSC diagnosis, or mutated gene (p > 0.05; <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRefs" href="#fig0005">Figs. 1 and 2</a> illustrate some of the main cutaneous findings in the TSC patients from this cohort, which were hypomelanotic macules (92.5%), angiofibromas (87.5%), cephalic plaques (80%), confetti-like lesions (67.5%), shagreen patches (55%), ungual fibromas (55%), and intraoral fibromas (25%). When each TSC skin lesion was individually considered there was no difference between sexes (p > 0.05; <a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>A). The number of angiofibromas was also similar between sexes (p = 0.31). Data collected from 37 patients (median age 16 [4‒41] years) that had been examined at two time points (Oct/2021, Oct/2022) disclosed no new skin lesion one year later.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">All 37 TSC patients had DNA assessed by sequencing, including two siblings. The 36 pathogenic DNA alterations were found in the <span class="elsevierStyleItalic">TSC1</span> gene in four unrelated individuals (11.1%) and in <span class="elsevierStyleItalic">TSC2</span> in 32 (88.9%) patients, defining a <span class="elsevierStyleItalic">TSC2</span>:<span class="elsevierStyleItalic">TSC1</span> mutation ratio of 8:1. There were three frameshifting variants and one large deletion in <span class="elsevierStyleItalic">TSC1</span>. The two siblings had a <span class="elsevierStyleItalic">TSC1</span> pathogenic mutation, summing up five individuals with alterations in this gene. <span class="elsevierStyleItalic">TSC2</span> mutations comprised seven frameshiftings, seven unique missense, six unique nonsense, three splicing, and three in-frame deletion variants, plus three large deletions and one large duplication. One <span class="elsevierStyleItalic">TSC2</span> nonsense variant was found in three unrelated patients, totaling 32 patients with <span class="elsevierStyleItalic">TSC2</span> mutations.</p><p id="par0060" class="elsevierStylePara elsevierViewall">The frequencies of <span class="elsevierStyleItalic">TSC1</span> and <span class="elsevierStyleItalic">TSC2</span> pathogenic alterations were similar between sexes (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>; p = 0.34). Age at first skin lesion onset and age at TSC diagnosis were available for 5 and 22 patients with <span class="elsevierStyleItalic">TSC1</span> and <span class="elsevierStyleItalic">TSC2</span> pathogenic DNA alterations, respectively. There were no significant differences between patient groups with distinct altered genes when comparisons were made for ages at first skin lesion, at TSC diagnosis, or type of first skin lesion (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>; p > 0.05).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">Ungual fibromas were more frequent among patients with <span class="elsevierStyleItalic">TSC2</span> than <span class="elsevierStyleItalic">TSC1</span> genetic alteration (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>B; 65.6% vs. 20.0%, for <span class="elsevierStyleItalic">TSC2</span> vs. <span class="elsevierStyleItalic">TSC1</span>; p = 0.07). The odds ratios estimated for specific skin lesions disclosed a ten-fold increase for ungual fibroma when a <span class="elsevierStyleItalic">TSC2</span> pathogenic alteration was present (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>A; Odds Ratio = 10.50, 95% Confidence Interval: 1.12–67.21, p = 0.03). The number of angiofibromas per patient was similar between patients harboring a pathogenic alteration in different genes (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>B; p = 0.64) and varied from zero to five (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>B).</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Discussion</span><p id="par0070" class="elsevierStylePara elsevierViewall">TSC-associated skin lesions should be recognized by general practitioners and pediatricians as they are commonly the first noticeable signs of this disease and comprise four of the eleven major criteria and three of the seven minor criteria for the clinical diagnosis of TSC (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Early diagnosis is important for follow-up and appropriate treatment initiation, limiting the growth of lesions and related morbidity. MTOR inhibitors received clinical approval as oral therapy for specific TSC lesions, such as everolimus to treat subependymal giant cell astrocytoma,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> renal angiomyolipoma,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> and as adjunctive treatment of TSC-partial onset seizures<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a>; and sirolimus (rapamycin) for lymphangioleiomyomatosis.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> In clinical studies, topical sirolimus decreases angiofibromas, hypomelanotic macules, or cephalic plaques, and is well tolerated by children.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12–14</span></a> Therefore, TSC skin lesions are not only important for the diagnosis of the disease but can be effectively treated by targeting mTOR hyperactivation.</p><p id="par0075" class="elsevierStylePara elsevierViewall">In this cohort of 37 patients with definite clinical and genetic diagnoses of TSC, the most common initial skin sign was hypomelanotic macules, which were also the most frequent dermatological presentation (92.5%). Hypomelanotic macules occur in approximately 90% of patients and have their onset usually at birth or in early childhood,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> as observed (n = 27 informative cases; mean age of 3 months; <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Other first skin signs less often observed were confetti-like lesions, fibrous cephalic or intraoral fibrous plaques (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Among one-month-old infants with at least one suggestive sign of TSC, hypomelanotic macules were the cause of the diagnosis suspicion in 31% of them.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> In patients up to four months of age, hypomelanotic macules were the initial sign in 35%.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> The present study did not assess non-dermatological signs. It confirms that among skin lesions hypomelanotic macules are the most frequent first sign in TSC patients (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><p id="par0080" class="elsevierStylePara elsevierViewall">Facial angiofibromas were the second most frequent lesion (87.5%), followed by cephalic plaques (80%). Overall angiofibroma estimated occurrence (75%)<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> rises in the second decade of life upon puberty.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Thus, angiofibromas’ frequency depends on the mean age of the patients at enrollment in the cohort. Shagreen plaques are generally observed from the first decade of life on, more commonly after five years of age,<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,16</span></a> in a frequency (50%) similar to the one observed by us (55%). Confetti-like lesions were detected in 67.5% of patients. They usually start in the first decade of life but have limited usefulness in adults as a diagnostic criterion, as they can develop as a consequence of chronic sun exposure.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> A history of onset in early childhood is suggestive of TSC.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Intraoral fibromas occur in 20%–50% of patients, more frequently in adults than in children.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Accordingly, the authors detected these lesions in ten TSC patients (25%). Skin lesion distribution was not different between sexes (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Gingival fibromas have been identified more frequently among males than females.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">The mean age at diagnosis was 18 months in this sample, 15 months later than the mean age at first skin sign detection, and later than the mean age at diagnosis from a recent study (n = 86; 6 months) that also adopted the same diagnostic criteria.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> In this German study, cardiac rhabdomyoma, a major TSC clinical criterion (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>), detected by prenatal fetal imaging contributed to diagnosing earlier the disease in 22% of cases.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> It appears that patients in the Brazilian cohort have heterogeneous access to fetal imaging analyses and depend more commonly on tertiary referral hospitals for the establishment of the TSC diagnosis.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Genetic testing is useful to confirm the diagnosis of TSC, particularly in clinically challenging cases in the early stages. In this analysis, <span class="elsevierStyleItalic">TSC1</span> and <span class="elsevierStyleItalic">TSC2</span> pathogenic variants were observed in 13.5% (5/37) and 86.5% (32/37) of patients, respectively, reasonably above the ratio observed by other studies.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17–21</span></a> The predominance of <span class="elsevierStyleItalic">TSC2</span> pathogenic genetic alterations, eight times more common than <span class="elsevierStyleItalic">TSC1</span> pathogenic variants, was observed among females (8-fold among females and 3.4-fold among males; <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). The chance of a <span class="elsevierStyleItalic">TSC2</span> mutation was 10-fold higher in the presence of ungual fibromas, although these data should be viewed with caution because of the wide confidence interval associated with the small number of cases with a <span class="elsevierStyleItalic">TSC1</span> mutation.</p><p id="par0095" class="elsevierStylePara elsevierViewall">A more severe neurological phenotype may be associated with <span class="elsevierStyleItalic">TSC2</span> mutation,<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17–21</span></a> while skin lesions and genotype association appear more variable among studies, except for facial angiofibromas. The TSC natural history database disclosed a significant association between <span class="elsevierStyleItalic">TSC2</span> mutation and angiofibromas.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> The mean grade of facial angiofibroma appears to be higher in patients with a <span class="elsevierStyleItalic">TSC2</span> than <span class="elsevierStyleItalic">TSC1</span> alteration.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> The authors did not observe a difference in the number of angiofibromas, which could be due to the low number of patients with a <span class="elsevierStyleItalic">TSC1</span> mutation, although there appears to be a trend of increasing numbers of angiofibromas in the presence of a <span class="elsevierStyleItalic">TSC2</span> gene mutation (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>A). In another study, children at age of two years with a <span class="elsevierStyleItalic">TSC1</span> gene mutation had less hypomelanotic macules and facial angiofibromas than those with a <span class="elsevierStyleItalic">TSC2</span> genetic alteration.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> By contrast, Shagreen patches have been observed more frequently in patients with a <span class="elsevierStyleItalic">TSC1</span> than <span class="elsevierStyleItalic">TSC2</span> gene alteration.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> Among 38 TSC patients with at least one cutaneous sign, dermatological examination alone was sufficient to establish a definite diagnosis of the disease in 34, demonstrating the importance of early recognition of skin lesions.<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24,25</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">The TSC cohort from a reference clinical center in Southern Brazil discloses the association between ungual fibromas and <span class="elsevierStyleItalic">TSC2</span> genetic alteration. One limitation is the small sample size and the limited number of patients with <span class="elsevierStyleItalic">TSC1</span> pathogenic variants. Further studies are necessary to evaluate TSC dermatological presentation association with genotype. The authors confirm the importance of detecting skin lesions for early identification of TSC. Clinicians should be aware of TSC's possible mucocutaneous lesions, their variable expressivity, and the natural history of the disease.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Financial support</span><p id="par0105" class="elsevierStylePara elsevierViewall">This research was supported by <span class="elsevierStyleGrantSponsor" id="gs0005">São Paulo Research Foundation</span> (FAPESP) grants <span class="elsevierStyleGrantNumber" refid="gs0005">2013/08028-1</span> and <span class="elsevierStyleGrantNumber" refid="gs0005">2019/10868-4</span> (São Paulo, Brazil), and <span class="elsevierStyleGrantSponsor" id="gs0010">CAPES (Process:</span><span class="elsevierStyleGrantNumber" refid="gs0010">88881.132401/2016-01;</span> Brasília, Brazil).</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Authors’ contributions</span><p id="par0110" class="elsevierStylePara elsevierViewall">Beatriz Azevedo Nunes: Study concept and design; data collection, analysis and interpretation; statistical analysis; writing of the manuscript; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Ana Karolina Ferreira Gonçalves Romano: Study concept and design; data collection, analysis and interpretation; statistical analysis; writing of the manuscript; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0120" class="elsevierStylePara elsevierViewall">Mariana Aparecida Pasa Morgan: Study concept and design; analysis and interpretation of data; statistical analysis; writing of the manuscript; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Alice Andrade Gonçalves: Data collection; writing of the manuscript; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Laís Faria Masulk Cardozo: Study concept and design; data collection; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0135" class="elsevierStylePara elsevierViewall">Luiz Gustavo Dufner de Almeida: Study concept and design; data collection, analysis and interpretation; statistical analysis; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0140" class="elsevierStylePara elsevierViewall">Luciana Amaral Haddad: Study concept and design; analysis and interpretation of data; statistical analysis; writing of the manuscript; effective participation in the research guidance; critical review of the literature; and final approval of the final version of the manuscript.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Ana Chrystina de Souza Crippa: Study concept and design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Sergio Antonio Antoniuk: Study concept and design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Kerstin Taniguchi Abagge: Study concept and design; analysis and interpretation of data; statistical analysis; effective participation in the research guidance; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; and final approval of the final version of the manuscript.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Conflicts of interest</span><p id="par0160" class="elsevierStylePara elsevierViewall">None declared.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres2241183" "titulo" => "Abstract" "secciones" => array:6 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Study limitations" ] 5 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1875177" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Subjects and methods" ] 4 => array:2 [ "identificador" => "sec0015" "titulo" => "Results" ] 5 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0025" "titulo" => "Financial support" ] 7 => array:2 [ "identificador" => "sec0030" "titulo" => "Authors’ contributions" ] 8 => array:2 [ "identificador" => "sec0035" "titulo" => "Conflicts of interest" ] 9 => array:2 [ "identificador" => "xack772919" "titulo" => "Acknowledgments" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2023-10-06" "fechaAceptado" => "2023-11-17" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1875177" "palabras" => array:5 [ 0 => "Genetic diseases" 1 => "Neurocutaneous syndromes" 2 => "Tuberous sclerosis complex" 3 => "Tuberous Sclerosis Complex 1 gene" 4 => "Tuberous Sclerosis Complex 2 gene" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Tuberous sclerosis complex (TSC) is a multisystem neurocutaneous syndrome with variable phenotypes. Recent updates of TSC diagnostic criteria reaffirmed the defined genetic diagnostic criterion as the finding of a pathogenic DNA alteration in either <span class="elsevierStyleItalic">TSC1</span> or <span class="elsevierStyleItalic">TSC2</span> genes. It also slightly modified definite clinical diagnostic criteria. TSC-associated skin lesions in infancy are important clinical signs to select individuals with possible TSC for a closer clinical follow-up and genetic testing.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">To raise awareness of the updated TSC diagnosis criteria; to assess the frequency of skin lesions in TSC patients as well as the first dermatological presentation; and to associate the findings with either <span class="elsevierStyleItalic">TSC1</span> or <span class="elsevierStyleItalic">TSC2</span> mutations.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methods</span><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Observational cross-sectional study. Clinical and genetic data were retrospectively collected from 37 TSC patients from a Brazilian University Hospital. Patients with skin signs were examined and prospectively assessed for 12 months.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">The earliest cutaneous lesions were hypomelanotic macules, which together with angiofibromas were the most frequent dermatological lesions. The total pathogenic DNA alteration ratio between <span class="elsevierStyleItalic">TSC2</span> and <span class="elsevierStyleItalic">TSC1</span> genes was 8:1. The frequency of a <span class="elsevierStyleItalic">TSC2</span> pathogenic variant was 10-fold greater in the presence of ungual fibromas.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Study limitations</span><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Small sample and a limited number of patients with <span class="elsevierStyleItalic">TSC1</span> pathogenic variants.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Conclusion</span><p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Clinicians should be knowledgeable about TSC updated diagnostic criteria. Patients need to be followed up by a multidisciplinary team and treated accordingly. Early detection of cutaneous lesions is important for TSC diagnosis. A significant association between <span class="elsevierStyleItalic">TSC2</span> gene pathogenic alterations and ungual fibromas is described.</p></span>" "secciones" => array:6 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Study limitations" ] 5 => array:2 [ "identificador" => "abst0030" "titulo" => "Conclusion" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0040">Study conducted at the Complexo Hospital de Clínicas Universidade Federal do Paraná, Curitiba, PR, Brazil.</p>" ] ] "multimedia" => array:7 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 978 "Ancho" => 1505 "Tamanyo" => 146336 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A‒B) Hypomelanotic macules on the patient’s abdomen (A) and shagreen plaque on the back of an adolescent patient (B).</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1106 "Ancho" => 1505 "Tamanyo" => 141278 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">(A‒B) Confetti-like lesions (arrows) in the anterior tibial region (A) and ungual fibromas in 4<span class="elsevierStyleSup">th</span> and 5<span class="elsevierStyleSup">th</span> fingers of an adult patient (B).</p>" ] ] 2 => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 981 "Ancho" => 3341 "Tamanyo" => 189121 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Frequency distribution of skin lesions by sex (A) and mutated gene (B). (A) Fisher’s exact test: Hypomelanotic macules: p = 0.23; Angiofibromas: p = 1.00; Cephalic plaques: p = 0.70; Confetti-like lesions: p = 0.50; Ungual fibromas: p = 0.53; Shagreen plaques: p = 0.33; Intraoral fibromas: p = 0.73. (B) Fisher’s exact test: Hypomelanotic macules: p = 0.44; Angiofibromas: p = 1.00; Cephalic plaques: p = 0.61; Confetti-like lesions: p = 0.18; Ungual fibromas: p = 0.07; Shagreen plaques: p = 0.42; Intraoral fibromas: p = 1.00.</p>" ] ] 3 => array:8 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 981 "Ancho" => 3341 "Tamanyo" => 134190 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0020" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Angiofibromas by mutated gene (A) and Odds Ratio of TSC skin lesions for <span class="elsevierStyleItalic">TSC2</span> mutations (B). (A) Pearson’s Chi-Square test: p = 0.64. (B) OR, Odds Ratio; Ungual fibromas: OR = 10.50; p = 0.03.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0025" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Underlined terms highlight updated criteria.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleUnderline">Definite TSC clinical diagnosis</span>: two major features or one major plus two or more minor features.</p><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleUnderline">Possible TSC clinical diagnosis</span>: one major criterion or at least two minor criteria.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Major criteria \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Minor criteria \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypomelanotic macules (≥ 3, at least 5-mm diameter) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">‘Confetti’ skin lesions \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Facial angiofibromas (≥ 3) or fibrous cephalic plaque \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dental enamel pits (≥ 3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ungual fibromas (≥ 2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Intraoral fibromas (≥ 2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Shagreen patch \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Retinal achromic patch \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Multiple retinal hamartomas \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Multiple renal cysts \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleUnderline">Multiple cortical tubers and/or radial migration lines</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Non-renal hamartomas \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Subependymal nodules (≥ 2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleUnderline">Sclerotic bone lesions</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Subependymal giant cell astrocytoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cardiac rhabdomyoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lymphangioleiomyomatosis<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Angiomyolipomas (≥ 2)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3652794.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Combination of these two major criteria without other features does not meet the criteria for a definite diagnosis.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Major and minor criteria for the clinical diagnosis of TSC according to Northrup et al., 2021.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p>" ] ] 5 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0030" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col">Age and skin lesion \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col">Female (n = 14) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col">Male (n = 13) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col">p \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">[Median (IIQ); n (%)] \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">[Median (IIQ); n (%)] \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Median age at first skin sign onset (months) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.0 (0‒19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3.0 (0‒7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.92<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Median age at TSC diagnosis (months) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18.0 (12‒36) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24.0 (7‒60) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.78 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">First cutaneous sign \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hypomelanotic leaf macula \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (92.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">13 (92.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.00<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Confetti-like lesion \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 (0.0%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 (15.4%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.22<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="